Bingham Private Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
4,319
-4,307
-50% -$1M 0.84% 32
2025
Q4
$755K Buy
+8,626
New +$1.71M 0.65% 37
2025
Q2
$574K Buy
8,728
+4,827
+124% +$742K 0.55% 52
2025
Q1
$647K Buy
3,901
+263
+7% +$41.2K 0.67% 46
2024
Q4
$526K Buy
+3,638
New +$564K 0.56% 58

Other funds holding JNJ

Bingham Private Wealth's JNJ Position: Q1 2026 in Review

Bingham Private Wealth reduced its Johnson & Johnson (JNJ) stake by 50% in Q1 2026, selling an estimated $1M and leaving 4,319 shares worth $1.06M. The position accounts for 0.84% of the portfolio, ranked #32.

Bingham Private Wealth first reported a position in JNJ in Q4 2024 and has held it in 5 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bingham Private Wealth held 4,319 shares of Johnson & Johnson worth $1.06M as of Q1 2026.
  • Bingham Private Wealth sold 4,307 Johnson & Johnson shares in Q1 2026, an estimated $1M.
  • Johnson & Johnson made up 0.84% of Bingham Private Wealth's portfolio in Q1 2026, its #32 holding.
  • Bingham Private Wealth first reported a position in Johnson & Johnson in Q4 2024 and has held it in 5 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bingham Private Wealth's 13F filing for Q1 2026, filed 7 May 2026.